Wolverine Asset Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Wolverine Asset Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,454	Closed	-$190K	–	2074
2023 Q1	$190K	Sell	18,454 -45,803	-71%	-$470K	﹤0.01%	1045
2022 Q4	$661K	Sell	64,257 -15,047	-19%	-$153K	0.01%	869
2022 Q3	$798K	Sell	79,304 -4,232	-5%	-$42.5K	0.01%	857
2022 Q2	$837K	Sell	83,536 -11,037	-12%	-$110K	0.01%	844
2022 Q1	$945K	Buy	94,573 +84,573	+846%	+$840K	0.01%	769
2021 Q4	$99K	Buy	+10,000	New	+$98.8K	﹤0.01%	1360

Wolverine Asset Management's IQMD Position: Q2 2023 in Review

Wolverine Asset Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q2 2023, closing a stake of 18,454 shares — an estimated $190K sold.

Wolverine Asset Management first reported a position in IQMD in Q4 2021 and held it in 6 quarters. The position peaked at $945K in Q1 2022. 0 funds tracked by Wall St. Rank hold IQMD as of Q2 2023.

Wolverine Asset Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Wolverine Asset Management sold 18,454 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $190K.
Wolverine Asset Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Wolverine Asset Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $945K in Q1 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.